IMMUNEONCO-B News

IMMUNEONCO-B: VOLUNTARY ANNOUNCEMENT - UPDATES ON THE CLINICAL TRIAL OF IMC-002

Jun 21 18:29

IMMUNEONCO-B: Monthly Return of Equity Issuer on Movements in Securities for the Month Ended 31 May 2024

Jun 5 11:25

IMMUNEONCO-B: VOLUNTARY ANNOUNCEMENT - APPROVAL BY NMPA FOR A PHASE III CLINICAL TRIAL OF IMM01 (TIMDARPACEPT) IN COMBINATION WITH AZACITIDINE FOR THE FIRST-LINE TREATMENT OF CMML

Jun 3 07:20

IMMUNEONCO-B: INSIDE INFORMATION - ISSUANCE OF FILING NOTICE BY THE CSRC FOR THE H SHARE FULL CIRCULATION OF CERTAIN UNLISTED SHARES OF THE COMPANY

May 29 22:47

IMMUNEONCO-B: List of Directors and their Role and Function

May 28 20:09

IMMUNEONCO-B: VOLUNTARY ANNOUNCEMENT - APPROVAL BY NMPA FOR A RANDOMIZED, DOUBLEBLIND, CONTROLLED PHASE III CLINICAL TRIAL OF IMM01 (TIMDARPACEPT) IN COMBINATION WITH AZACITIDINE

May 17 16:32

IMMUNEONCO-B: Monthly Return of Equity Issuer on Movements in Securities for the Month Ended 30 April 2024

May 7 16:14

IMMUNEONCO-B: Proxy Form for the Annual General Meeting to be held on May 28, 2024

Apr 29 18:57

IMMUNEONCO-B: VOLUNTARY ANNOUNCEMENT - APPROVAL BY NMPA FOR THE PHASE III CLINICAL TRIALPROTOCOL OF IMM01 (TIMDARPACEPT)

Apr 17 18:16

IMMUNEONCO-B: Monthly Return of Equity Issuer on Movements in Securities for the Month Ended 31 March 2024

Apr 8 12:01

IMMUNEONCO-B: VOLUNTARY ANNOUNCEMENT - UNUSUAL PRICE MOVEMENTS

Mar 6 22:19

IMMUNEONCO-B: Monthly Return of Equity Issuer on Movements in Securities for the Month Ended 29 February 2024

Mar 4 16:59

IMMUNEONCO-B: LIST OF DIRECTORS AND THEIR ROLES AND FUNCTIONS

Mar 4 07:06

IMMUNEONCO-B: (1) RESIGNATION OF EXECUTIVE DIRECTOR,CHIEF FINANCIAL OFFICER ANDAUTHORIZED REPRESENTATIVE;(2) PROPOSED APPOINTMENT OF EXECUTIVE DIRECTOR;AND(3) APPOINTMENT OF AUTHORIZED REPRESENTATIVE

Mar 1 22:00

IMMUNEONCO-B: Notification Letter and Reply Form to Non-registered Shareholders - Arrangement of Electronic Dissemination of Corporate Communications

Feb 20 16:36

IMMUNEONCO-B: Notification Letter and Reply Form to Registered Shareholders - Arrangement of Electronic Dissemination of Corporate Communications

Feb 20 16:31

IMMUNEONCO-B: Monthly Return of Equity Issuer on Movements in Securities for the Month Ended 31 January 2024

Feb 5 11:32

IMMUNEONCO-B: Monthly Return of Equity Issuer on Movements in Securities for the Month Ended 31 December 2023

Jan 5 10:13

IMMUNEONCO-B: Monthly Return of Equity Issuer on Movements in Securities for the Month Ended 30 November 2023

Dec 5, 2023 16:39

IMMUNEONCO-B: VOLUNTARY ANNOUNCEMENT - FIRST PATIENT DOSED IN THE PHASE II CLINICAL TRIAL OFIMM2510 FOR THE TREATMENT OF ASPS

Nov 20, 2023 12:23